601 N Mur-Len Road, Suite 9,
Olathe, Kansas, 66062, USA
Catain Labs has been working with a commercial-stage neuroscience specialty pharmaceutical company for the last 8 years and has helped them develop several novel 505(B)(2) Oral Liquid formulations for the same.
| Product Candidate | Formulation | Therapeutic Area | Phase | ||||
|---|---|---|---|---|---|---|---|
| Early Development | Early Clinical | Advanced Clinical | NDA Submission | Commercialization | |||
| Neuroscience Product 001 | Oral Liquid | Neurology and Psychiatry | |||||
| Neuroscience Product 002 | Oral Liquid | Neurology | |||||
| Neuroscience Product 003 | Oral Liquid | Psychiatry | |||||
| Neuroscience Product 004 | Oral Liquid | Psychiatry | |||||
| Neuroscience Product 005 | Oral Liquid | Psychiatry | |||||
Catain Labs is also working on other 505(B)(2) Oral Liquid formulation and are looking for licensing partner to commercialize the product.
| Product Candidate | Formulation | Therapeutic Area | Phase | ||||
|---|---|---|---|---|---|---|---|
| Early Development | Early Clinical | Advanced Clinical | NDA Submission | Commercialization | |||
| CLL-001 | Oral Liquid | Pulmonary | |||||
| CLL-002 | Oral Liquid | Pulmonary | |||||
| CLL-003 | Oral Liquid | Pulmonary | |||||
Catain Labs also has developed several generic products including but not limited to tablets, suspensions, solutions, nasal spray, ophthalmic solutions and suspensions, otic solution and injectable.
Catain Labs is also currently involved in development of novel Over-The-Counter (OTC) ophthalmic solution and emulsion.
601 N Mur-Len Road, Suite 9,
Olathe, Kansas, 66062, USA